TCS CEO corrects three major Nashik facts: Nida Khan was not HR head, unit not shut, no POSH complaints on record
Read More Pharma Industry News Mirum Pharmaceuticals raises $120m to advance Maralixibat for rare liver diseases Mirum Pharmaceuticals, a clinical-stage pharmaceutical company, has successfully raised $120 million in a Series A funding round to… bypharmanewsdailyDecember 2, 2018
